Cargando…
Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma
BACKGROUND: Current diagnostic and prognostic blood-based biomarkers for neuroendocrine tumors are limited. MiRNAs have tumor-specific expression patterns, are relatively stable, and can be measured in patient blood specimens. We performed a multi-stage study to identify and validate characteristic...
Autores principales: | Bowden, Michaela, Zhou, Chensheng W., Zhang, Sui, Brais, Lauren, Rossi, Ashley, Naudin, Laurent, Thiagalingam, Arunthi, Sicinska, Ewa, Kulke, Matthew H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589584/ https://www.ncbi.nlm.nih.gov/pubmed/28903345 http://dx.doi.org/10.18632/oncotarget.16908 |
Ejemplares similares
-
Treatment Patterns and Health Resource Use Among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated at a Tertiary Referral Center
por: Jalbert, Jessica J., et al.
Publicado: (2020) -
OR06-02 TBR-760, a Chimeric Somatostatin-Dopamine Compound, Arrests Aggressive Non-Functioning Pituitary Adenoma Growth In Vivo
por: Halem, Heather A, et al.
Publicado: (2020) -
Association Between Tumor Progression Endpoints and Overall Survival in Patients with Advanced Neuroendocrine Tumors
por: Ter‐Minassian, Monica, et al.
Publicado: (2017) -
The intestinal microbiota influences the microenvironment of metastatic colon cancer by targeting miRNAs
por: Zhou, Shihai, et al.
Publicado: (2022) -
Identification of Ovarian Cancer Metastatic miRNAs
por: Vang, Souriya, et al.
Publicado: (2013)